as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
6.35%
Downside
1.95%
Upside
52 Week's Low
52 Week's High
82.30%
Downside
43.10%
Upside
Check Lexeo Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$614.6M
EPS (TTM)
-2.4295
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.48
Industry PE ratio
0PEG Ratio
0EBITDA
-112.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-80.69%
Track how Lexeo Therapeutics P/E has moved over time to understand its valuation trends.
Lexeo Therapeutics in the last 5 years
Lowest (-3.79x)
September 30, 2024
Industry (0.00x)
November 8, 2025
Today (-6.48x)
November 8, 2025
Highest (-0.94x)
December 31, 2023
Today’s Price to Earnings Ratio: -6.48x
Compare market cap, revenue, PE, and other key metrics of Lexeo Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $614.6M | NA | -6.48 | 0.00% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Lexeo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lexeo Therapeutics investment value today
Current value as on today
₹1,07,522
Returns
₹7,522
(+7.52%)
Returns from Lexeo Therapeutics Stock
₹2,375 (+2.37%)
Dollar Returns*
₹5,147 (+5.15%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Lexeo Therapeutics. Average target price of $19.56
Get share price movements and forecasts by analysts on Lexeo Therapeutics.
What analysts predicted
58.13%UPSIDE
Target Price
$19.56
Current Price
$8.19
Analyzed by
11 Analysts
Target
$19.56
Lexeo Therapeutics target price $19.56, a slight upside of 58.13% compared to current price of $8.19. According to 11 analysts rating.
Search interest for Lexeo Therapeutics Stock has increased by 400% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:400% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -32.65M → -20.28M (in $), with an average increase of 26.9% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 37.0K → 1.94M (in $), with an average increase of 82.9% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 147.3%
Price Dip
![]()
In the last 7 days, LXEO stock has moved down by -15.9%
| Organisation | Lexeo Therapeutics |
| Headquarters | 345 Park Avenue South, New York, NY, United States, 10010 |
| CEO | Mr. R. Nolan Townsend |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jose Manuel Otero Ph.D. | Chief Technical Officer |
Dr. Ronald G. Crystal M.D. | Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory Board |
Mr. Louis Tamayo | CFO & Principal Accounting Officer |
Mr. Jordan M. Baumhardt Ph.D. | Vice President of Corporate Development |
Ms. Leslie DiRisio | Senior Vice President of Development Operations |
Mr. R. Nolan Townsend | CEO & Director |
Dr. Eric Adler M.D. | Chief Medical Officer & Head of Research |
Ms. Jenny R. Robertson J.D. | Chief Legal Officer |
Dr. Sandi See Tai M.D. | Chief Development Officer |
Mr. Ryan McHenry | VP & Corporate Controller |
Lexeo Therapeutics share price today is $8.19 as on at the close of the market. Lexeo Therapeutics share today touched a day high of $8.35 and a low of $7.67.
Lexeo Therapeutics share touched a 52 week high of $11.72 on and a 52 week low of $1.45 on . Lexeo Therapeutics stock price today i.e. is closed at $8.19,which is 30.12% down from its 52 week high and 464.83% up from its 52 week low.
Lexeo Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Lexeo Therapeutics (LXEO) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Lexeo Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lexeo Therapeutics share’s latest price of $8.19 as on November 8, 2025 at 2:29 am IST, you will get 1.2210 shares of Lexeo Therapeutics. Learn more about
fractional shares .